Best supportive care (BSC) with or without low-dose chemotherapy (chemo) in frail elderly patients with advanced gastroesophageal cancer (aGOAC): The uncertain randomization of the GO2 phase III trial.

Swinson, D, Hingorani, M, Stokes, Z et al. (15 more authors) (2019) Best supportive care (BSC) with or without low-dose chemotherapy (chemo) in frail elderly patients with advanced gastroesophageal cancer (aGOAC): The uncertain randomization of the GO2 phase III trial. In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, USA. American Society of Clinical Oncology , p. 4051.

Metadata

Authors/Creators:
  • Swinson, D
  • Hingorani, M
  • Stokes, Z
  • Dent, J
  • Guptal, K
  • Chatterjee, A
  • Kamposioras, K
  • Grumett, SA
  • Khan, M
  • Marshall, H ORCID logo https://orcid.org/0000-0003-0944-0152
  • Ruddock, S
  • Allmark, C
  • Katona, E
  • Howard, HC
  • Velikova, G
  • Lord, S
  • Hall, PS
  • Seymour, MT
Dates:
  • Accepted: 29 March 2019
  • Published: 20 May 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
FunderGrant number
Cancer Research UKA14923
Depositing User: Symplectic Publications
Date Deposited: 16 Oct 2019 11:20
Last Modified: 29 Jun 2020 13:35
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: https://doi.org/10.1200/JCO.2019.37.15_suppl.4051
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)